Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature review

Balconi, Francesca; Garcia-Alvarez, Alejandro; Hernando, Jorge; OConnor, Juan Manuel; Chacon, Matias; Tissera, Natalia Soledad; Capdevila Castillon, Jaume

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Balconi, Francesca
dc.contributor.author	Garcia-Alvarez, Alejandro
dc.contributor.author	Hernando, Jorge
dc.contributor.author	OConnor, Juan Manuel
dc.contributor.author	Chacon, Matias
dc.contributor.author	Tissera, Natalia Soledad
dc.contributor.author	Capdevila Castillon, Jaume
dc.date.accessioned	2025-03-11T09:43:46Z
dc.date.available	2025-03-11T09:43:46Z
dc.date.copyright	2024
dc.date.issued	2025-01
dc.identifier.citation	Tissera NS, Balconi F, García-Álvarez A, Hernando Cubero J, O’Connor JM, Chacón M, et al. Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature review. Cancer Treat Rev. 2025 Jan;132:102863.
dc.identifier.issn	0305-7372
dc.identifier.uri	http://hdl.handle.net/11351/12739
dc.description	Quimioteràpia de primera línia; Teràpia de manteniment; Carcinoma neuroendocrí
dc.language.iso	eng
dc.publisher	Elsevier
dc.relation.ispartofseries	Cancer Treatment Reviews;132
dc.rights	Attribution-NonCommercial 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc/4.0/
dc.source	Scientia
dc.subject	Aparell digestiu - Càncer - Quimioteràpia
dc.subject	Aparell digestiu - Prevenció
dc.subject	Tumors neuroendocrins
dc.subject.mesh	Carcinoma, Neuroendocrine
dc.subject.mesh	/drug therapy
dc.subject.mesh	Maintenance Chemotherapy
dc.title	Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature review
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1016/j.ctrv.2024.102863
dc.subject.decs	carcinoma neuroendocrino
dc.subject.decs	/farmacoterapia
dc.subject.decs	quimioterapia de mantenimiento
dc.relation.publishversion	https://doi.org/10.1016/j.ctrv.2024.102863
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Tissera NS, García-Álvarez A, Hernando Cubero J, Capdevila J] Upper Gastrointestinal and Endocrine Tumor Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Balconi F] Medical Oncologist, Oncological Hospital Armando Businco Cagliari, Cagliari, Italy. [O'Connor JM] Instituto Alexander Fleming, GI Clinical Oncology, Buenos Aires, Argentina. [Chacón M] Head of the Oncology Department, Alexander Fleming Institute, Buenos Aires, Argentina
dc.identifier.pmid	39721305
dc.identifier.wos	001394634500001
dc.rights.accessrights	info:eu-repo/semantics/openAccess